BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 10586241)

  • 1. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
    Müller HW
    Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Vistas on the Pathomechanism of Charcot-Marie-Tooth and Related Peripheral Neuropathies.
    Müller HW
    Ann N Y Acad Sci; 1999 Oct; 883(1):152-159. PubMed ID: 29086935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
    Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
    Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.
    Nelis E; Haites N; Van Broeckhoven C
    Hum Mutat; 1999; 13(1):11-28. PubMed ID: 9888385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies.
    Zielasek J; Toyka KV
    Ann N Y Acad Sci; 1999 Sep; 883():310-20. PubMed ID: 10586256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.
    Sahenk Z
    Ann N Y Acad Sci; 1999 Sep; 883():415-26. PubMed ID: 10586265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
    Mersiyanova IV; Ismailov SM; Polyakov AV; Dadali EL; Fedotov VP; Nelis E; Löfgren A; Timmerman V; van Broeckhoven C; Evgrafov OV
    Hum Mutat; 2000; 15(4):340-7. PubMed ID: 10737979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
    Hanemann CO; Müller HW
    Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in nodes of Ranvier and Schmidt-Lanterman incisures in Charcot-Marie-Tooth neuropathies.
    Sahenk Z; Mendell JR
    Ann N Y Acad Sci; 1999 Sep; 883():508-12. PubMed ID: 10586286
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
    Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
    Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anatomy and cell biology of peripheral myelin protein-22.
    Snipes GJ; Orfali W; Fraser A; Dickson K; Colby J
    Ann N Y Acad Sci; 1999 Sep; 883():143-51. PubMed ID: 10586240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schwann cell-axon interactions in Charcot-Marie-Tooth disease.
    Griffin JW; Sheikh K
    Ann N Y Acad Sci; 1999 Sep; 883():77-90. PubMed ID: 10586234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mouse models of CMT1A and HNPP.
    Suter U; Nave KA
    Ann N Y Acad Sci; 1999 Sep; 883():247-53. PubMed ID: 10586249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M; Berger P; Nave KA; Suter U
    Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.